Property:BGT Accepted Therapeutic Use For(P302)

From BiomedGT

Jump to: navigation, search

BGT_Accepted_Therapeutic_Use_For(P302)

Lexical

Concept Code: P302
Preferred Name: Accepted_Therapeutic_Use_For
Coding Scheme: BGT (08.11a )
Synonym: Accepted_Therapeutic_Use_For (PT) (Source: NCI)
Definition: Indicates a disease or condition for which this drug is an accepted treatment. Used in Chemicals and Drug Kind. (Source: NCI)
URI: http://ncicb.nci.nih.gov/xml/owl/EVS/BiomedGT.owl:P302

Properties

Semantic_Type: Conceptual Entity
NCI_META_CUI: CL337299

Associations



Type:String

Facts about BGT Accepted Therapeutic Use For(P302)RDF feed
BGT NCI META CUI(P208) CL337299  +info.pngNCI META CUI lookup
BGT Semantic Type(P106) Conceptual Entity  +info.pngSemantic Type lookup
BGT Synonym(P104) Accepted_Therapeutic_Use_For  +
DCTerms hasVersion(hasVersion) BGT/Versions/08.11a  +
Has typeThis property is a special property in this wiki.StringThis type is among the standard datatypes of this wiki.
LexWiki Concept Code P302  +
LexWiki Definition Indicates a disease or condition for which this drug is an accepted treatment. Used in Chemicals and Drug Kind. (Source: NCI)
LexWiki Preferred Name Accepted_Therapeutic_Use_For  +
LexWiki URI http://ncicb.nci.nih.gov/xml/owl/EVS/BiomedGT.owl:P302  +
SKOS inScheme(inScheme) BGT  +

Pages using the property “BGT Accepted Therapeutic Use For(P302)”

Showing 18 pages using this property.

B

Category:BGT 111InIbritumomab Tiuxetan(B2752) +Non-Hodgkins lymphoma  +
Category:BGT 111InSatumomab Pendetide(B1642) +Radiodetection of ovarian cancer  +
Category:BGT 11CAcetate(B38885) +Diagnostic imaging  +
Category:BGT 11CMethionine(B1707) +PET radiopharmaceutical  +
Category:BGT 131IMetaiodobenzylguanidine(B1143) +Diagnostic imaging  +
Category:BGT 131ITositumomab(B2617) +CD-20-antigen-expressing, relapsed or refractory, low-grade, follicular, or transformed Non-Hodgkins lymphoma  +
Category:BGT 177LuMonoclonal Antibody J591(B38874) +None current  +
Category:BGT 18FFludeoxyglucose(B1137) +Radiopharmaceutical, cancer diagnostic  +
Category:BGT 4 Hydroxytamoxifen(B1148) +None current.  +
Category:BGT 4 Iodo 4 Deoxydoxorubicin(B1144) +None current.  +
Category:BGT 7 Cyanoquinocarcinol(B1784) +None current.  +
Category:BGT 7 Hydroxystaurosporine(B1444) +None current  +
Category:BGT 89SrStrontium Chloride(B1411) +Palliation of pain in bone metastases  +
Category:BGT 90YIbritumomab Tiuxetan(B1985) +Non-Hodgkin's Lymphoma, Indolent, advanced-stage follicular lymphoma  +
Category:BGT 90YMonoclonal Antibody Hu3S193(B38851) +None current  +
Category:BGT 99mTcArcitumomab(B1667) +Colorectal carcinoma and medullary thyroid carcinoma detection  +
Category:BGT 99mTcSulfur Colloid(B1029) +Diagnostic imaging  +
Category:BGT Abarelix(B2188) +Prostate Cancer  +
Personal tools